Ignite Creation Date:
2025-12-25 @ 2:16 AM
Ignite Modification Date:
2025-12-29 @ 3:02 AM
Study NCT ID:
NCT05763160
Status:
COMPLETED
Last Update Posted:
2023-11-18
First Post:
2023-02-28
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
An Open-label Study That Will Test a Second Treatment Session of RZL-012.
Sponsor:
Raziel Therapeutics Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
RZL-012-SMF-2nd-P2US-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None